Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2016First federal award
$2.2MFederal grants as PI4 awards
2Patents grantedLatest May 26, 2026
74Papers4,653 citations
Federal awards and patents by year
AwardsPatents
4 awards · $2.2M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Feb 5, 2022 | NIH | SBIR Phase I Developing non-anticoagulant recombinant heparin for treating the COPD Pathogenic Triad | $322K | TEGA THERAPEUTICS INC |
| Dec 16, 2020 | NSF | SBIR Phase II SBIR Phase II: Development of Bioengineered Anticoagulant Heparin from a Non-Animal Source | $1.4M | TEGA THERAPEUTICS INC |
| Feb 1, 2019 | NSF | SBIR Phase I SBIR Phase I: Bioengineered Recombinant Anticoagulant Heparin | $225K | TEGA THERAPEUTICS INC |
| Jul 1, 2016 | NSF | STTR Phase I STTR Phase I: Biomanufacture of Novel Heparan Sulfate Glycosaminoglycans | $225K | TEGA THERAPEUTICS INC with State University of New York |
3 patents as inventor
- US 11549000TEGA THERAPEUTICS INCJan 10, 2023
- US 12636307TEGA THERAPEUTICS INCMay 26, 2026
- US TEGA THERAPEUTICS INC—
Matched by the first inventor’s name and the patent’s company.
Peer ranks
Federal funding#918
Awards as PI#566
Patents#102
Companies
- TEGA THERAPEUTICS INCLinked by awards · Biotech
Research institutions
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.